We are live on
!
Find out more
BCAM
Boston Common Asset Management Portfolio holdings
AUM
$1.69B
1-Year Est. Return
28.29%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+28.29%
3 Year Est. Return
+54.94%
5 Year Est. Return
+54.02%
10 Year Est. Return
+260.31%
AUM
$802M
AUM Growth
+$42.8M
(+5.6%)
Cap. Flow
-$11.8M
Cap. Flow
% of AUM
-1.47%
Top 10 Holdings %
Top 10 Hldgs %
29.13%
Holding
202
New
15
Increased
102
Reduced
54
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$3.67M |
| 2 |
Trip.com Group
TCOM
|
+$3.05M |
| 3 |
Oracle
ORCL
|
+$2.16M |
| 4 |
Albemarle
ALB
|
+$1.44M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$1.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$10.9M |
| 2 |
Sociedad Química y Minera de Chile
SQM
|
+$5.35M |
| 3 |
Equifax
EFX
|
+$4.61M |
| 4 |
Alibaba
BABA
|
+$4.11M |
| 5 |
Toronto Dominion Bank
TD
|
+$2.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.08% |
| 2 | Healthcare | 13.98% |
| 3 | Financials | 12.35% |
| 4 | Consumer Discretionary | 8.56% |
| 5 | Industrials | 6.92% |
Similar funds
GAM
FACM
TCBWMS
PP
ISS
BA
RMC
BCM
Boston Common Asset Management's Q3 2017 Portfolio in Review
As of Q3 2017, Boston Common Asset Management held 202 positions worth $802M, up 5.6% from $759M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Boston Common Asset Management's Q3 2017 filing shows 15 new, 102 increased, 54 reduced and 13 closed positions. Its largest new stake was Berkshire Hathaway Class A: 5 shares worth $1.37M. The largest sale was Teva Pharmaceuticals, an estimated $10.9M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Boston Common Asset Management's largest Q3 2017 buy was Berkshire Hathaway Class A: 5 shares worth $1.37M.
- Boston Common Asset Management added most to Applied Materials in Q3 2017, an estimated $3.67M increase.
- Boston Common Asset Management's biggest Q3 2017 reduction was Sociedad Química y Minera de Chile, cutting an estimated $5.35M.
- Boston Common Asset Management fully exited Teva Pharmaceuticals in Q3 2017, selling an estimated $10.9M.
- Boston Common Asset Management's ten largest holdings make up 29% of its $802M portfolio in Q3 2017.
- Boston Common Asset Management opened 15 new positions and closed 13 in Q3 2017.
- Boston Common Asset Management's portfolio value rose 5.6% quarter-over-quarter to $802M.
Based on Boston Common Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.